![](/img/cover-not-exists.png)
O-278: Economic impact of the FSH choice (urinary or recombinant) on ART cost. Data from a new randomized controlled trial
J. De Mouzon, J. Urbancsek, B. Salle, B. Nicollet, J. Antoine, G.D. GrudzinskasVolume:
86
Year:
2006
Language:
english
DOI:
10.1016/j.fertnstert.2006.07.317
File:
PDF, 48 KB
english, 2006